Since nonsense mutations are closely associated with severe conditions of genetic disorders, including familial cancers, rapid and precise detection of those mutations is very important for research purposes and molecular diagnosis. Currently, screening methods such as the FASAY (functional analysis of separated alleles in yeast) and the Y-SC (stop codon assay in yeast) are used for functional detection of nonsense mutations in genes of interest. But these yeast-based approaches are time-consuming, expensive and complicated. In order to circumvent these problems, we, in the present study, devised a novel Escherichia coli-based screening method, the E-SC (E. coli stop codon assay) for the detection of heterozygous nonsense mutations in genes of interest. Our strategy was based on the fact that the plasmid replicating with a low copy number in E. coli allows an effective separation of normal and mutant alleles. Moreover, it relies on the expression vector, resulting in the formation of white and blue colonies for mutant and normal alleles through the expression of PCR-amplified fragment/lacZ fusion protein respectively. To evaluate the applicability of the E-SC method for the detection of the heterozygous truncating mutation, PCR-amplified exon 7 of the StAR [steroidogenic acute regulatory protein; causative gene of the CAH (congenital lipoid adrenal hyperplasia)] and RT (reverse transcription)-PCR-amplified fulllength cDNA of MeCP2 (methyl-CpG-binding protein 2; causative gene of Rett syndrome) were used. The E-SC showed an almost 1:1 ratio of blue/white colonies in all patients examined, whereas the control samples produced blue colonies only. These results demonstrate that the E-SC system is useful for rapid and precise detection of known and unknown heterozygous truncation mutations in genes that cause genetic disorders and familial cancers.
Introduction
Molecular diagnosis of complex inherited disorders and cancers involves screening for mutations in multiple DNA samples [1] . The identification of these mutations is important for their characterization, but also for genetic counselling, prenatal or presymptomatic diagnosis, as well as for research purposes. Recently, DNA-based methods to detect causative mutations of genetic disorders and cancers have been developed. They include: the PCR-SSCP (PCR-single-strand conformational polymorphism); the CSGE (conformation sensitive gel electrophoresis), heteroduplex analysis; the CFLP (cleavage-fragment-length polymorphism); the direct DNA sequencing; and the DNA chip-based method [2] [3] [4] [5] [6] . Of gene product-based methods, the PTT (protein truncation test) is based on the in vitro transcription-translation of PCR-amplified fragments of the gene and the detection of truncated peptides by SDS/PAGE/Western blotting [7] . PTT is an effective method to detect truncating mutations also known as nonsense mutations. But these molecular-biology-based approaches require comprehensive experimental skills, and are timeconsuming and expensive. The gel-running-based methods such as SSCP, CSGE and CFLP also require expensive and complicated gel running and staining processes. Importantly, the larger the size of DNA fragment to be analysed (SSCP, > 200 bp; direct sequencing, > 700 bp), the more primers, PCR and direct sequencing reactions are required. Also, the problems are maximized when the number of exons of the target gene is increased.
More recently, methods such as the FASAY (functional analysis of separated alleles in yeast) and the Y-SC (stop codon assay in yeast) were introduced for the screening of mutations in genes of interest [8, 9] . The FASAY is based on the colour change of the yeasts according to the status of genes introduced into them [8, 10] . The Y-SC is the method that utilizes homologous recombination of PCRamplified cDNA with special vector construct to separate alleles. It involves the production of a marker fusion protein that tests truncating mutations in genes of interest such as those coding for BRCA1 (breast-cancer susceptibility gene 1), APC (adenomatous polyposis coli), E-cadherin and hMSH6 (human MutS homologue 6) [9, 11, 12] . Many of the cancers in colon, breast and ovary, and genetic disorders are caused by heterozygous truncating mutations. Therefore the FASAY and Y-SC can be reliable for their molecular diagnosis. However, those yeast-based methods require a period for the growth of the transformed yeast (at least 5 days), a system for the culture of the yeast and selection reagents that are relatively complicated. In order to avoid those problems, the present study devised a simple SC assay system that uses the E-SC (Escherichia coli stop codon assay) for the detection of heterozygous truncating mutations in genes of interest as an alternative to the Y-SC. The assay involved the use of plasmid vector with a very low copy number to ensure an effective separation of alleles. It also involved expression of PCRamplified fragment-lacZ fusion protein. The heterozygous nonsense mutation in genes of interest was detected by the blue/white colony formation of the E. coli. In order to ascertain the applicability of the E-SC for the detection of truncation mutations in genes of interest, CAH (congenital lipoid adrenal hyperplasia) caused by nonsense mutations at exon 7 of the StAR (steroidogenic acute regulatory protein) gene was tested using genomic PCR [13] .
Usually, mutation screening via genomic PCR of causative genes for various cancers and genetic diseases is limited to a number of exons constituting the genes. The more the numbers of exons to be analysed, the more screening reactions are required. The practical use of the full-length cDNA instead of the genomic DNAs of all exons involved in the gene of interest would solve such a problem and permit the screening of unknown truncation mutation of the gene. In the present study, the full-length cDNA of the MeCP2 (methyl-CpG-binding protein 2) gene that has been recently known as a causative gene of RS (Rett syndrome) was employed to test the efficiency of the heterozygous mutation detection of the E-SC [14] .
The overall objective of the present study was to develop the E-SC for the detection of both known and unknown heterozygous nonsense mutations in targeted genes using the genomic PCR and the full-length cDNA by RT (reverse transcription)-PCR respectively.
Materials and methods

Preparation of screening vector
In the present study, plasmid vector pZC320, which has a low copy number and which was kindly given by Dr Donald P. Biek (Laboratoire de Microbiologie et Génétique Moleculaire, CNRS, Toulouse, France), was used as a screening vector for the E-SC [15] . Plasmids were purified using Qiagen plasmid kit (Qiagen) and digested with XhoI and BamHI. The linearized gap vector was re-purified using a GENECLEAN II kit (BIO 101) before being used for ligation with PCR-amplified fragments.
PCR amplification of exon 7 of the StAR gene
In the present study, the Korean lipoid CAH family consists of a female patient who was diagnosed as a typical lipoid CAH sufferer, her parents and her unborn sibling. The parents did not show any symptoms of lipoid CAH. Genomic DNAs of patient and family members were prepared from fresh blood and CVS (chorionic villus sampling) (unborn sibling) with a Wizard genomic DNA purification kit (Promega), and were used for the PCR amplification. The exon 7 of the StAR gene was amplified from genomic DNA. The PCR amplification of genomic DNA was carried out with the forward primer StAR7-F (5 -ccgctcgaggggtggctgcccaagagcatc-3 ) and reverse primer StAR7-R (5 -cgggatcccaacacctggcttcagaggcag-3 ). We designed the primers with nucleotide sequences from 23 to 137 of GenBank ® accession number U29105, the coding region of exon 7 of the StAR gene. Each of the primers was designed to contain XhoI and BamHI linker at 5 -end (underlined bases) for in-frame ligation of amplified exon 7 with pZC320 gap vector. The PCR reaction was performed in 50 µl volume containing 1 µg of genomic DNA, 5 µl of 10 × Taq polymerase buffer (100 mM Tris/HCl, pH 8.3, 500 mM KCl and 15 mM MgCl 2 ), 20 pmol of each primer and 2.5 units of Taq DNA polymerase (Takara Shuzo, Shiga, Japan). The PCR condition was pre-denaturation at 94
• C for 5 min, then 25 cycles at 94
• C for 20 s, at 58
• C for 20 s and at 72
• C for 20 s, and at 72
• C for 5 min for the final extension. The PCR products were analysed on a 1.5 %-(w/v)-agarose gel. The products were extracted and digested with XhoI and BamHI to give the compatible end with pZC320 gap vector for the in-frame ligation.
The E-SC XhoI/BamHI-digested fragments of the amplified exon 7 of the StAR gene were ligated into pZC320 gap vector. The ligation reaction was carried out for 30 min at 16
• C in 10 µl volume containing the gap vector (100 ng) and the digested fragment (the vector/insert ratio of 1:10) using a Rapid Ligation kit (Roche). The E. coli strain DH5α was transformed with the ligation product by the routine heat-shock method [16] . The transformed DH5α was then plated and grown at 37
• C for 14-16 h on LB (Luria-Bertani) plate containing 50 µg/ml ampicillin, 40 µl of 20 mg/ml X-Gal (5-bromo-4-chloroindol-3-yl β-D-galactopyranoside) and 7 µl of 200 mg/ml IPTG (isopropyl β-D-thiogalactoside) for α-complementation and blue/white screening. After colony formation, blue and white colonies were counted with the naked eye to determine the percentage of blue colonies.
Recovery of the cloned fragment and DNA sequencing Transformed blue/white colonies were grown and recombinant plasmids were then recovered by an alkaline-lysis method using a Qiagen plasmid kit (Qiagen). The presence of the amplified exon 7 of the expected size was confirmed by PCR using the primers StAR7-F and StAR7-R. The PCR products were extracted and sequenced by a DNA sequencing kit AccuPower TM (Bioneer) using the dideoxy-nucleotide chain-termination method and electrophoresed on 6 % polyacrylamide gel containing 40 % (w/v) urea at 25 mA for 2 h [17] . The electrophoresed gel was subjected to by silver staining. That is, the gel was fixed with 10 % (v/v) acetic acid for 20 min and washed three times with deionized water for 2 min. Then, the gel was stained with 0.1 % silver nitrate, washed with deionized water and soaked in developing solution [37 % formaldehyde (1.5 ml/l), 10 mg/ml sodium thiosulfate (200 µl/l) and sodium carbonate (30 g/l)] until sequencing bands were detected. Finally, the developed gel was fixed with 10 % acetic acid.
RT-PCR amplification of MeCP2 and the E-SC
Total RNAs were extracted using TRI Reagent (Molecular Research Center, Cincinnati, OH, U.S.A.) from lymphoblastoid cells derived from RS patients [18] . cDNAs were synthesized at 42
• C for 1.5 h in 30 µl volume containing 6 µl of 5 × RT buffer (1 × RT buffer is 50 mM Tris/HCl, pH 8.3, 50 mM KCl, 8.0 mM MgCl2 and 10 mM dithiothreitol), 4 µl of 2.5 mM dNTPs, 500 ng of oligo(dT) primer, 2 µg of total RNA and 300 units of Moloney-murine-leukaemia virus-RT (Promega). The RT-PCR amplification was carried out with the forward primer MeCP2-F (5 -cgctcgagatggtagctgggatgttaggg-3 ) and the reverse primer MeCP2-R (5 -cgggatccctaactctctcggtcacggg-3 ), to amplify the entire coding region of the MeCP2 cDNA. We designed the primers with nucleotide sequences from 168 to 1624 of GenBank ® accession number NM004992, the coding region of full-length mRNA of the MeCP2 gene. Each of the primers was designed to contain XhoI and BamHI linker at 5 -end (underlined bases). The PCR reaction was performed in 50 µl volume containing 3 µl of cDNA, 5 µl of 10 × Taq polymerase buffer (100 mM Tris/HCl, pH 8.3, 500 mM KCl and 15 mM MgCl 2 ), 20 pmol of each primer and 2.5 units of Taq DNA polymerase (Takara). The PCR underwent a pre-denaturation at 94
• C for 5 min, then 40 cycles at 94
• C for 60 s, at 57
• C for 60 s and at 72
• C for 100 s, and at 72
• C for 5 min for final extension. The PCR products were analysed on a 1.5 % agarose gel. The products were extracted and digested with XhoI and BamHI before being used for the E-SC.
Results
The schema of the E-SC Mini F Plasmid pZC320, used as a screening vector in the present study, was derived from an F plasmid and maintained at very low copy (1.4 copies/cell) in E. coli [15] . The MCS (multiple cloning site) of pZC320 contained 16 unique restriction sites and was positioned within the 5 -end of the lacZ gene, which enabled β-galactosidase α-complementation in the E. coli. Since the pZC320 was a very-low-copy-number plasmid, it allowed the separation of alleles, hence the detection of heterozygous nonsense mutation in the genes of interest. The plasmid that contains the normal allele fragment cloned into the MCS within lacZ expressed in-frame amplified fragment/lacZ fusion protein in E. coli. Also, the expression of the fusion protein resulted in the formation of blue colonies by normal α-complementation when both X-Gal and IPTG were included in culture medium. In contrast, the plasmid containing the fragment amplified from the mutant allele expressed no normal fusion protein because of a stop codon in the amplified fragment, resulting in the formation of white colonies. The outline of the E-SC assay is summarized in Scheme 1.
Screening of nonsense mutations at exon 7 of the StAR gene by the E-SC using genomic DNA The exon 7 of the StAR gene was amplified by genomic PCR using a set of primers (StAR7-F and StAR7-R) from lymphoblastoid cells derived from a lipoid CAH family. The PCR products were 129 bp long and were directly sequenced. As a result, it was confirmed that a lipoid CAH patient had a nonsense mutation and the parents turned out to have the same heterozygous mutation with patient in exon 7 of the StAR gene (258CGA > TGA [Q258X]; results not shown).
The PCR-amplified exon 7 of the StAR gene, which was confirmed to have the nonsense mutation [C 258 GA → TGA (Q258X) where X is a stop codon] in a lipoid CAH patient, was inserted into the XhoI/BamHI site of the pZC320. The E. coli transformation on the growth medium containing the X-Gal/IPTG was subsequently performed.
The transformation with the ligation products that contained the amplified fragment from the lipoid CAH patient produced 185 colonies, consisting of 100 blue colonies and 85 white colonies (Table 1) . That is, the PCR products derived from the genomic DNA of patients with known heterozygous StAR mutations showed an almost 1:1 ratio of blue to white colonies. By contrast, the fragment derived from the normal allele produced a total of 159 colonies, consisting of 158 blue ones and only one white one.
Scheme 1 Outline of the E-SC assay
Mini F Plasmid pZC320, used as a screening vector in the present study, was derived from F plasmid and maintained at very low copy number (1.4 copies/cell) in E. coli. The fragments amplified by genomic and RT-PCR from normal alleles were inserted into the MCS of pZC320 vector. The cloned pZC320 could express the in-frame amplified fragment/lacZ fusion protein in E. coli, resulting in the formation of a blue colony by normal α-complementation when the culture media included both X-Gal and IPTG. In contrast, the pZC320 plasmids, which were inserted by the fragments from mutant alleles with nonsense mutations, would fail to express the normal fusion protein, resulting in the formation of white colonies. Table 1 shows the results of the E-SC using the amplified exon 7 fragment of the StAR gene. The genomic DNAs from parents were analysed with the E-SC, and the ratio of blue to white colonies in father and mother were 95:64 and 92:67 respectively. The E-SC of the CVS for prenatal diagnosis of unborn siblings was also performed and resulted in 91.5 % blue colonies (blue/white = 152:14). Therefore the unborn siblings were presumed normal. After birth, they were confirmed with no symptoms of lipoid CAH.
DNA sequence analysis of the cloned fragments isolated from blue/white colonies
The pZC320 plasmid screening vector was stably maintained at a copy number of one or two per cell (1.4 copies/cell). Consequently, it was assumed that the blue and white colonies contained only the normal and the mutant alleles in the vector respectively. With the objective of confirming that allele separation of amplified fragment was successfully Figure 1 Sequencing analysis of colonies formed by insertion into pZC320 of the fragments amplified from exon 7 of the StAR gene A CAH patient showed both C and T at affected position, whereas blue and white colonies showed C and T respectively. Arrows indicate the position of affected nucleotides.
achieved, the PCR and DNA sequencing analyses of the amplified fragments of the plasmid vectors isolated from each of the blue/white colonies were performed.
The blue colonies contained the normal fragment of exon 7 of StAR, whereas the white colonies contained the fragment that had the single base-pair substitution causing protein truncation at the codon commencing at position 258 (C 258 GA → TGA; Figure 1 ). This nonsense mutation found in the amplified fragment was identical with the mutation of lipoid CAH patient described above.
Application of the E-SC for screening of nonsense mutations in the MeCP2 gene
The genomic PCR-based E-SC could be applicable for the detection of known nonsense mutation. However, it is occasionally insufficient for the detection of unknown nonsense mutations in genes of interest. For example, genes consisting of many exons require numerous experimental reactions and an extended period for molecular-based mutation analysis. That makes it difficult for a rapid, easy and accurate detection of the heterozygous nonsense mutations. In the present study, a full-length cDNA of MeCP2 known as a causative gene of RS was applied for the detection of unknown nonsense mutation within entire exons of the gene to overcome the problem.
Using a set of primers encompassing the entire coding region of the MeCP2 gene, RT-PCR products of 1456 bp were obtained from lymphoblastoid cells of three RS patients (results not shown). The patients were previously diagnosed with the heterozygous nonsense mutations [patient 1, C808T (R270X); patients 2 and 3, C763T (R255X)] [18] . A control from a normal individual was made. These amplified fragments were purified, digested with XhoI/BamHI and used for ligation with pZC320 gap vector. The detection a The ratio of blue colonies to total colonies was calculated with data obtained by repeating the experiment five times.
of nonsense mutations in the amplified fragments was performed using our E-SC method described above. The ratio of blue colonies to the total colonies was calculated with the data generated after repeating the experiment five times. The RT-PCR products derived from the lymphocytes of RS patients led to 42.5-63.3 % of blue colonies with an average of 53.3 + − S.D. That resulted in a ratio of blue and white colonies close to 1:1. On the other hand, the fragment derived from a normal individual (control) produced 83.7-95.5 % of blue colonies with an average of 89 % ( Table 2 ). This result indicated that our E-SC could also be used for the detection of unknown nonsense mutations in large genes consisting of many exons.
Discussion
In 1997, Ishioka et al. [9] first described an efficient and simple mutation screening method, the Y-SC. It utilizes a marker gene, URA3, and gap repair and homologous recombination to insert a PCR-generated sequence into the fusion construct for efficient separation of the products of different [11, 12, 19] . The present paper describes a simple, inexpensive and time-saving method, the E-SC, which could detect heterozygous nonsense mutation in genes of interest. Both the Y-SC and E-SC are universal high-throughput screening systems that could separate allele effectively without gel running and detect mutations according to the colours of colonies of the vector hosts. However, the E-SC uses the E. coli-based system, which is easy to handle compared with the yeast-based assay. The new assay does not require the complicated culture system needed for yeast, expensive selection reagents, extended growth period, gel electrophoresis or technical expertise (Table 3) . The E-SC just requires the pZC320 vector that is applicable for detection of nonsense mutations in known or unknown positions of genes of interest.
The E-SC utilizes the plasmid vector pZC320 with a very low copy number. Also, the vector allows alleles separated through cell division and expresses the cloned fragment-lacZ fusion protein. No details were given on maximum insert size of the vector that can be inserted, but it worked successfully with full-length cDNA of over 2 kb. This means that the E-SC can be applicable for screening genes consisting of many exons. pZC320 expressing mutant PCR-amplicon or full-length cDNA from patients who have heterozygous nonsense mutations would show a near 1:1 ratio of blue colonies/white colonies, whereas normal individuals (controls) generate only blue colonies. That is, the E-SC provides an effective separation of allele of target genes and, therefore, enables the simple detection of heterozygous truncating mutations by blue/white colonies selection. In addition, counting the numbers of blue/white colonies with the naked eye and calculating the ratio of blue colonies/white colonies are the only things that should be done for our E-SC. Also, the E-SC is easy to use compared with the Y-SC because it just requires the E. coli culture system. Furthermore, its procedure can be completed in 2 days at the longest, whereas the Y-SC requires at least 4-5 days (Table 3) . Although false positives and false negatives in colonies with normal and nonsense mutants appear, it could be ignored compared with the Y-SC [12] . In case of the E-SC using full-length mRNA ( Table 2 ; the blue colonies are a little more than white colonies in experiments with patients), a cellular process called 'nonsensemediated mRNA decay' could be considered. Accordingly, RNA molecules containing premature translation-truncating mutations could be specifically degraded [20] . It might cause false-negative colonies in the experiment with nonsense mutant and influence the ratio of blue colonies/white colonies. However, it would not be a critical obstacle in distinguishing nonsense mutants from normal samples.
The E-SC, compared with other mutation screening methods such as SSCP, CFLP, CSGE and PTT, is nonradioactive, sensitive and it is not necessary to run gels. In addition, the E-SC ensures that frameshifts/nonsense mutations up to the end of the 3 -end of the PCR fragment are detected. The other advantage of the assay is that there is no need for additional time-consuming cloning step of each normal and mutant allele after mutation screening. As this assay itself provides an efficient cloning system of cDNA fragments over 2 kb, it facilitates sequence determination of missense mutations from E. coli blue colonies as well as nonsense mutations from white colonies. Combined with sequencing, it can also be used as a high-throughput subcloning system for detection of missense mutations. The cloned DNA also could be applied for additional analysis, such as a protein functional study or for long-term storage.
The E-SC was able to detect nonsense mutation of full-length cDNA of MeCP2. It proved that the assay would be applicable for the detection of the nonsense mutation at unknown positions of the genes. The assay would be more especially useful in the case of a gene of interest with many exons to be analysed.
Protein truncating mutations constitute the majority of inactivating mutations for a number of important cancer and genetic disorders. Furthermore, the difficulty in interpreting missense mutations precludes their use in most clinical diagnostics. The E-SC thus provides a rapid and reliable test that can be readily adapted to detect heterozygous truncating mutations in causative genes of genetic disorders and other genes implicated in human disease.
In human genetic diseases and cancers, although the spectrum of mutations ranges from cytogenetically visible chromosomal arrangements to single-base alterations, the most prevalent mutation is nonsense mutations (more than 50 %) leading to truncation of proteins [21] . Particularly in Korea and Japan, nonsense mutation of exon 7 of the StAR gene was detected in 80 % of lipoid CAH patients [22] . It means that the E-SC would be used for the molecular diagnosis of various genetic diseases and cancers.
The results mentioned above strongly demonstrate that the E-SC is a rapid, easy and useful method for the detection of mutant alleles that cause genetic disorders and familial cancers with heterozygous truncating mutations in genes.
